12th Annual Congress of International Drug Discovery Science & Technology (IDDST2014)

Dear Friends and Colleagues,

it is a great honor to welcome you to the 12th Annual Congress of International Drug Discovery Science and Technology (IDDST-2014).

IDDST-2014 will be held at Suzhou of China during November 18-20, 2014. It aims to offer professionals in the field of drug discovery a multidisciplinary platform to discuss and to share knowledge about the latest scientific discoveries and current industry standards.

The IDDST congress, initiated by BIT Life Sciences in 2003, is dedicated to supporting the pharmaceutical professionals and bioscientists to exchange ideas, network, seek partnership overseas, pinpoint and identify opportunities and global drug R & D market demand, get updated on the latest breakthroughs in innovative new drugs, networking, and explore business development in across cultural environment. With 10 years’ of persistent efforts by 400 full time BIT employees working on meeting organization, IDDST has successfully attracted more than 5,000 world renowned speakers with over 50,000 professionals around the world as a leading international event for our drug discovery community.

Through IDDST-2014, we hope to offer further intelligence exchange opportunities for global professionals in booming drug research and development industry and its partnering potential in Asia. It is our wish that all participants in this congress can gain a greater understanding of the current trend of the market, such as the strategies of major pharmaceutical companies in integrating scientific, technological, and business resources to increase their competitive capacities, in order to succeed in their respective fields.

I would like to thank each individual and organization that have worked so hard to make IDDST 2014 a successful conference. The organizing committee, steering committee, and program committee all worked long hours and put in many creative efforts to make it a success.
Finally, I express my deep appreciation to all the participants of this conference! It is due to your keen interest that IDDST can expand and explore the frontier breakthrough of modern drug discovery for our scientific community. We hope you will enjoy the conference and IDDST can help your professional development and establish your business network.

Executive Chair
Dr. Xiaodan Mei, President of BIT Congress Inc., China

Advisory Board Members
Mr. Lonnie O. Moulder, Chief Executive Officer, TESARO, USA
Dr. Mingde Xia, Senior Director, Johnson & Johnson Innovation Center, USA
Dr. Grace Wong, CEO, ActoKine Therapeutics, USA
Dr. Lars-Gunnar Larsson, Professor, Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Sweden
Dr. Willem J Riedel, Vice President of Science, Cambridge Cognition Ltd, UK
Dr. Xi Yang, Professor, Department of Medical Microbiology and the Department of Immunology, University of Manitoba, Canada
Dr. Claude Nicolau, Professor, Friedman School Tufts University, USA
Dr. Xiaoyan Jiang, Senior Scientist and Associate Professor, Department of Medical Genetics, University of British Columbia, Canada
Dr. Qiming Jane Wang, Associate professor, Vice Chair of Regulatory Affairs, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, USA
Dr. Udo Maier, Head of Target Discovery Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Dr. David F. Woodward, Senior Director, Department of Biological Sciences, Allergan Inc., USA
Dr. Dexian Zheng, Professor, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, China
Dr. Jung S. Huang, Professor, Department of Biochemistry and Molecular Biology, St. Louis University School of Medicine, USA
Dr. Gayane Badalian Very, Scientist, Division of Medical Oncology, Dana-Farber Cancer Institute, USA
Dr. Georgia Z. Chen, Professor, Department of Hematology and Medical Oncology, Emory University, USA
Dr. Karol Jackowski, Full Professor of Chemistry, Laboratory of NMR Spectroscopy, Warsaw University, Poland
Dr. Jan de Sonneville, Founder and CEO, Life Science Methods BV, the Netherlands
Dr. Niro Ramachandran, R&D Manager, Life Technologies, USA
Dr. Xiaowu Liang, CEO, Antigen Discovery Inc., USA
Dr. Iwao Ojima, Distinguished Professor, Director, Institute of Chemical Biology & Drug Discovery, Stony Brook University, USA
Dr. Christopher R. Triggle, Professor of Pharmacology & Assistant Dean Admissions, Departments of Medical Education and Pharmacology, Weill Cornell Medical College in Qatar, Qatar
Dr. Min Liu, Professor, Department of Pathology , Metabolic Diseases Institute, University of Cincinnati, USA
Dr. Kathryn Uhrich, Professor and Dean, Mathematical & Physical Sciences, Rutgers University, USA
Dr. Cynthia Siu, Vice President, Data Power (DP), Inc, USA
Dr. Walter E Müller, Professor, University Frankfurt Biocenter, Germany
Dr. Rivka Ravid, Director, Brain Bank Consultants, Netherlands
Dr. Helen G. Durkin, Professor of Pathology, State University of New York Downstate Medical Center, USA
Dr. Georg Rueedi, Associate Director, Anti-Infectives Chemistry, Actelion Pharmaceuticals Ltd., Switzerland
Dr. May Orfali, Senior Director, Rare Diseases Department, Pfizer, USA
Dr. Li-Jun Yang, Associate Professor, Division of Hematopathology, University of Florida College of Medicine, USA
Dr. Rolf G. Werner, Professorship for Industrial Biotechnology, Eberhard Karls University of Tuebingen, Germany
Dr. Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation, USA
Dr. Jian Wu, Distinguished Professor, Fudan University Shanghai Medical College, China
Dr. Zhihong Xu, Associate Professor, St. Cloud State University; Adjunct Associate Professor, Duke University, USA
Dr. Ching jer Chang, Professor of Medicinal Chemistry, Purdue University, USA
Dr. Thomas Högberg, Senior Scientific Advisor, LEO Pharma, Denmark
Dr. Alan Xiao, Director, Clinical Pharmacology and DMPK at AstraZeneca, USA
Dr. Anfan Wu, Head of Early Development, Roche R&D Center, China
Dr. Parviz Ghahramani, Vice President, Head of Early Development, Forest Research Institute, USA

Tongli Lakeview Hotel (Suzhou Expo)
Add: No.8 Jiulihu Road,Tongli Town,Wujiang District, Suzhou City, Jiangsu Province,P.R.C
Cod: 215217
Tel: 86-512-63337888-5040
Fax: 86-512-63322966
Web: http://www.tonglilakeviewhotel.com

The hotel possesses 500 luxury rooms, which are all face to beautiful lake or natural eco-garden. On the principle of providing the best service for the customer, all members of our team undergoing strictly train according to requirement of five star hotel of national standard.

This conference provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you.
Some companies have been thinking of ways that events can help their business, let me show you the 6 ways that you will benefit from this grand event
 

Smart marketers spend a lot of time deciding how to "position" their products or services in the consumer's mind. If you DO choose the right positioning for your product or service, and communicate it forcefully to your target audience, you can ultimately build a strong brand identity that can have enduring value.
 

With the quality and number of visitors in attendance, exhibiting at this conference gives you brand exposure to the sort of people who will actually buy your services. Remember, being in the same room as your competitors only increases brand awareness if your customers are there to see you...
 

This conference will extend business, networking and learning opportunities beyond the event venue and successfully acts as a bridge between China and the international market
 

It is not only a conference but also a platform that you can meet your clients, prospects and friends or seek potential business opportunity

It is an ideal medium for test marketing or launching new products. New buying interests can be uncovered and otherwise unaccessible buyers appear in front of your exhibit.

We will give a discount to our regular exhibitors from 10% to 20%. If this is the first conference, we will encourage potential exhibitors to attend this event by some concessions.